AM-125 in the Treatment of Acute Peripheral Vertigo Following Neurosurgery
Status:
Recruiting
Trial end date:
2022-01-01
Target enrollment:
Participant gender:
Summary
Treatment of vertigo after removal of a tumor of the balance and hearing nerve after
neurosurgery, which damages or cuts the vestibular nerve (balance).
This trial explores the efficacy and safety of AM-125 in the treatment of acute vertigo. In
this proof of concept trial patients experiencing vertigo after neurosurgery (vestibular
schwannoma labyrinthectomy and vestibular neurectomy) will receive AM-125 or placebo. It
evaluates the potential of AM-125 versus placebo in reducing the symptoms of vestibular
dysfunction and accelerating vestibular compensation following neurosurgery.